ASSET SALE AND PURCHASE AGREEMENTAsset Sale and Purchase Agreement • December 13th, 2018 • AzurRx BioPharma, Inc. • Pharmaceutical preparations
This ASSET SALE AND PURCHASE AGREEMENT (together with all Exhibits attached hereto, as any of the foregoing may be amended, consolidated, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of the 5th day of December, 2018 (the “Execution Date”), by and between PROTEA BIOSCIENCES, INC., a Delaware corporation, and PROTEA BIOSCIENCES GROUP, INC., a Delaware corporation (collectively, the “Seller”), and AZURRX BIOPHARMA, INC., a Delaware corporation (“Buyer” or “AzurRx”). Seller and Buyer are each sometimes referred to individually herein as a “Party”, and collectively as the “Parties”.
